To clarify the clinical significance of TOX3-WDR5/ABCG2 signaling axis in CRC progression, we divided the 94 patients into 2 groups based on the CRC tissue microarray, with or without lymph node metastasis for clinical analysis. This evidence concerns the gene ABCG2 and metastatic malignant neoplasm in the lymph nodes.